Screener
BioCryst Pharmaceuticals BCRX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from BioCryst Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's operating margin?
- BioCryst Pharmaceuticals (BCRX) reported operating margin of -33.3% in Q2 2026.
- How has BioCryst Pharmaceuticals's operating margin changed year-over-year?
- BioCryst Pharmaceuticals's operating margin decreased by 442.5% year-over-year, from 9.7% to -33.3%.
- What is the long-term trend for BioCryst Pharmaceuticals's operating margin?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's operating margin has grown at a -47.5% compound annual growth rate (CAGR), from -981.1% to 39%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about BioCryst Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude